Surgical Science Sweden AB (publ)
SUSRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $264 | $209 | $251 | $252 |
| % Growth | 26% | -16.6% | -0.3% | – |
| Cost of Goods Sold | $93 | $73 | $78 | $81 |
| Gross Profit | $170 | $136 | $173 | $170 |
| % Margin | 64.6% | 65.2% | 68.8% | 67.6% |
| R&D Expenses | $55 | $52 | $55 | $52 |
| G&A Expenses | $20 | $23 | $44 | $22 |
| SG&A Expenses | $77 | $81 | $97 | $72 |
| Sales & Mktg Exp. | $56 | $58 | $53 | $50 |
| Other Operating Expenses | $11 | $25 | -$3 | $7 |
| Operating Expenses | $143 | $159 | $149 | $131 |
| Operating Income | $27 | -$22 | $24 | $39 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |
| Other Income/Exp. Net | $3 | $4 | $22 | $0 |
| Pre-Tax Income | $30 | -$19 | $46 | $39 |
| Tax Expense | $10 | $1 | $13 | $3 |
| Net Income | $20 | -$20 | $33 | $36 |
| % Margin | 7.7% | -9.6% | 13.3% | 14.4% |
| EPS | 0.4 | -0.39 | 0.65 | 0.71 |
| % Growth | 202.6% | -160% | -8.5% | – |
| EPS Diluted | 0.4 | -0.39 | 0.65 | 0.71 |
| Weighted Avg Shares Out | 51 | 51 | 51 | 51 |
| Weighted Avg Shares Out Dil | 51 | 51 | 51 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $4 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $27 | -$22 | $24 | $39 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |